Specifications
Immunogen
Normal human peripheral blood granulocytes
Applications
Application Notes
Flow Cyt: Neat - 1/5;
Target
Alternative Names
FCGR3A; Fc fragment of IgG, low affinity IIIa, receptor (CD16a); CD16; FCG3; CD16A; FCGR3; IGFR3; IMD20; FCR-10; FCRIII; FCGRIII; FCRIIIA; low affinity immunoglobulin gamma Fc region receptor III-A; FcgammaRIIIA; CD16a antigen; fc-gamma RIII; Fc-gamma RII
Product Background
Pathway
Adaptive Immune System; FCGR activation; Fc gamma R-mediated phagocytosis; Fcgamma receptor (FCGR) dependent phagocytosis; Immune System; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell; Innate Immune System; Leishmaniasis;
Citations
Have you cited CABT-45622MH in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Paz-Ares, L; Balint, B; et al. A Randomized Phase 2 Study of Paclitaxel and Carboplatin with or without Conatumumab for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY 8:329-337(2013).
Nishio, M; Endo, T; et al. FCGR3A-158V/F polymorphism may correlate with the levels of immunoglobulin in patients with non-Hodgkin's lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation. EUROPEAN JOURNAL OF HAEMATOLOGY 82:143-147(2009).
PDF
Certificate of Analysis
